Início
Mercados
Gráficos e ideias
Algo
Notícias
Market
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Heatmap
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
PBYI
#3128
PUMA BIOTECHNOLOGY INC
7.5
7
USD
0.00%
Setor:
Cuidados de saúde
Base:
USD
Moeda do lucro:
USD
Faixa diária
Faixa anual
Mudança diária
0.00%
Mudança mensal
+26.17%
Mudança em 6 meses
+41.76%
Mudança anual
+158.36%
Fechamento anterior
7.5
7
Abrir
7.5
7
Bid
Ask
Mínimo
7.5
7
High
7.5
7
Volume
34
Mercados
Ações
Cuidados de saúde
PBYI
Abrir gráfico completo
Financials
Visão geral
Relatórios
Estatísticas
Trimestral
Ano
Valor
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
40.26 M
41.33 M
46.64 M
48.21 M
49.61 M
50.88 M
—
Valuation ratios
Enterprise value
434.43 M
179.16 M
230.71 M
211.05 M
110.85 M
279.1 M
734.12 M
Price to earnings ratio
—
—
—
10.06
4.92
9.75
24.09
Price to sales ratio
—
—
0.81
0.91
0.65
1.32
3.91
Price to cash flow ratio
—
—
-11.72
7.97
3.85
7.21
21.86
Price to book ratio
—
—
8.59
4.03
1.63
2.31
3.9
Enterprise value to EBITDA ratio
-15.46
31.37
3.68
4.31
2.83
7.56
17.36
Profitability ratios
Return on assets %
-0.25
-0.13
0
0.09
0.14
0.14
0.15
Return on equity %
10.08
11.91
0
0.4
0.33
0.24
0.27
Return on invested capital %
-116.13
4.51
0.4
104.46
128.94
130.27
131.57
Gross margin %
100
74.84
75.84
73.4
72.06
74.53
300.6
Operating margin %
-13.51
0.51
10.4
13.85
13.44
16.33
61.56
EBITDA margin %
-9.42
0.79
13.86
13.15
12.6
15.81
68.6
Net margin %
-26.65
-11.51
0
9.16
13.14
13.62
51.67
Liquidity ratios
Quick ratio
1.25
1.21
1.67
1.5
1.45
1.93
6.6
Current ratio
1.28
1.28
1.73
1.57
1.54
2
6.99
Inventory turnover
—
12.06
9.47
10.8
8.15
8.17
7.06
Asset turnover
0.94
1.08
1.02
1.04
1.04
1.06
1.13
Solvency ratios
Debt to assets ratio
0.44
0.51
0.51
0.34
0.13
0.03
0.23
Debt to equity ratio
-17.92
-47.69
5.29
1.45
0.31
0.05
0.42
Long term debt to total assets ratio
0.34
0.43
0.44
0.28
0.1
0
0.11
Long term debt to total equity ratio
-14.12
-39.69
4.55
1.23
0.24
0
0.21
Per share metrics
Operating cash flow per share
—
—
-0.35
0.57
0.79
0.83
0.83
EBIT per share
—
—
0.53
0.69
0.63
0.74
0.74
EBITDA per share
—
—
0.7
0.65
0.59
0.71
0.86
Total debt per share
—
—
2.54
1.63
0.59
0.12
0.9
Cash per share
—
—
1.04
1.03
1.77
1.81
6.96
Net current asset value per share
—
—
2.99
3.28
3.01
3.21
11.41
Tangible book value per share
—
—
-1.09
-0.16
0.83
1.76
5.29
Working capital per share
—
—
1.26
1.19
1.05
1.61
4.87
Book value per share
—
—
0.48
1.12
1.88
2.57
8.87
Puma Biotechnology Inc
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
Notícias
Editas (EDIT) Up 3.8% Since Last Earnings Report: Can It Continue?
Agios Pharmaceuticals (AGIO) Moves 14.3% Higher: Will This Strength Last?
Receita do NERLYNX da Puma Biotechnology sobe 15% no 4º tri de 2025
Puma Biotechnology reporta resultados robustos no 4º tri de 2025
Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why
IRWD vs. PBYI: Which Small-Cap Biotech Stock Is a Better Buy?
Puma Biotech na conferência da TD Cowen: crescimento estratégico e disciplina financeira
PBYI Q4 Earnings & Sales Beat Estimates, Stock Down on Weak 2026 View
Puma Biotechnology, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:PBYI) 2026-02-27
Puma Biotech (PBYI) Q4 Earnings and Revenues Beat Estimates
Jazz Pharmaceuticals (JAZZ) Beats Q4 Earnings and Revenue Estimates
Exelixis (EXEL) Q4 Earnings and Revenues Beat Estimates